About
Technology
Issues
FAQ
Links
Official Page
Rosuvastatin for Primary Prevention Among Individuals With Elevated High-Sensitivity C-Reactive Protein and 5% to 10% and 10% to 20% 10-Year Risk
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.